Lifecore Biomedical, Inc. (LFCR) has entered a 10-year commercial manufacturing and supply agreement with an existing partner to advance a new ophthalmic treatment through clinical stages to market ...

EDTA has gained use in ophthalmic solutions owing to its ability to bind metals. Therapeutically, EDTA has been used to remove calcified plaques that occur in the superficial cornea in band ...

Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...

Here’s how it works. The best cloud storage for photos keeps your precious memories safe and lets you manage your collection from anywhere. With photos and videos eating up more space ...

Oculoplastics can provide comprehensive ophthalmologists with an opportunity to improve patient care, expand their services ...

In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix Pro, the Johnson & Johnson Vision Tecnis Odyssey and the Bausch + Lomb enVista Envy ...

Outlook Therapeutics, Inc. (Nasdaq:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

We're All Ears for Celebrity Buzz! Please enter a name. Please enter a valid email. Please enter a phone number. Please enter a message. Send the Tip! Us Weekly has affiliate partnerships so we ...